Global Insulin Antidiabetics Market to reach USD 75 billion by 2023 - PowerPoint PPT Presentation


PPT – Global Insulin Antidiabetics Market to reach USD 75 billion by 2023 PowerPoint presentation | free to download - id: 85bb93-MTI3Y


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation

Global Insulin Antidiabetics Market to reach USD 75 billion by 2023


For more details visit @ Antidiabetics Market to be dominated by some notable industry participants includingTakeda, Merck, Boehringer Ingelheim, Oramed, Pfizer, Novo Nordisk, Eli Lilly and Sanofi Aventis. – PowerPoint PPT presentation

Number of Views:10


Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Global Insulin Antidiabetics Market to reach USD 75 billion by 2023

Antidiabetics Market share to reach USD 116.1
billion by 2023
Fuel Cell Market size worth 25.5bn by 2024
Key Insights of Antidiabetics Market
  • Geriatric demographic and obesity patients are
    likely to exhibit higher diabetes rates and will
    be the main drivers of this industry accounting
    for 360 million diabetes cases by 2023.
  • Diabetes as a global health concern is being
    addressed by the government through various
    campaigns to inform and educate people about the
    effects and consequences of this disease and
    thus, motivate them to take effective measures
    for its control.
  • For instance, NIDDK (National Institute of
    Diabetes and Digestive and Kidney Diseases) has
    organized educational campaigns like Control
    your diabetes for life,Small Steps, etc. to
    spread awareness about the importance of diabetes
  • Multinational pharmaceutical companies like
    Pfizer, Merck, GlaxoSmithKline, Novartis, Eli
    Lilly, Sanofi, AstraZeneca are aiming towards
    expanding their market across 57.2 million people
    by 2025.
  • Expanding their respective product portfolios
    will be the major growth strategy adopted by
    these players over the coming years. Generic drug
    manufacturers will also witness high growth
    opportunities in this market taking advantage of
    the reliance factor on low cost medicines.

  • The Asia Pacific antidiabetics market is forecast
    to reach USD 28 billion by 2023. India and China
    are anticipated to be the revenue pockets due to
    high patient pool across these regions.
  • In addition to this, the regional growth will be
    fueled by increasing penetration rates of insulin
    analogs. The European market is estimated to
    register a CAGR of 9 from 2016-2023. The growth
    is mainly attributed to the large obese
    population in this region.
  • North America insulin antidiabetic market share
    worth USD 22.2 billion in 2015, will witness a
    noticeable surge in the coming years, driven by
    factors like better healthcare facilities in
    terms of accessibility, high disposable income,
    and favorable reimbursement policies.
  • Antidiabetics market is becoming highly
    competitive with a variety of industry
    participants entering into the business space.
    Generic drug manufacturers have high scope
    wherein they can drive the revenue by
    manufacturing biosimilar medicines.

Europe Insulin Antidiabetics Market size, 2015
2023, (USD Million)


Browse Full Market Research Report Antidiabetics
Market _at_ http// Request for a
Sample of this Research report _at_
Stay In Touch Website https//
Social Media